A gerophysiology perspective on healthy ageing.

Healthy ageing Homeostasis-allostasis Inflammation Metabolism Repair processes Stroma

Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
01 2022
Historique:
received: 17 06 2021
revised: 23 11 2021
accepted: 03 12 2021
pubmed: 10 12 2021
medline: 29 1 2022
entrez: 9 12 2021
Statut: ppublish

Résumé

Improvements in public health and health care have resulted in significant increases in lifespan globally, but also in a significant increase in chronic disease prevalence. This has led to a focus on healthy ageing bringing a shift from a pathology-centered to an intrinsic capacity and function-centered view. In parallel, the emerging field of geroscience has promoted the exploration of the biomolecular drivers of ageing towards a transverse vision by proposing an integrated set of molecular hallmarks. In this review, we propose to take a step further in this direction, highlighting a gerophysiological perspective that considers the notion of homeostasis/allostasis relating to robustness/fragility respectively. While robustness is associated with homeostasis achieved by an optimal structure/function relationship in all organs, successive repair processes occurring after daily injuries and infections result in accumulation of scar healing leading to progressive tissue degeneration, allostasis and frailty. Considering biological ageing as the accumulation of scarring at the level of the whole organism emphasizes three transverse and shared elements in the body - mesenchymal stroma cells/immunity/metabolism (SIM). This SIM tryptich drives tissue and organ fate to regulate the age-related evolution of body functions. It provides the basis of a gerophysiology perspective, possibly representing a better way to decipher healthy ageing, not only by defining a composite biomarker(s) but also by developing new preventive/curative strategies.

Identifiants

pubmed: 34883201
pii: S1568-1637(21)00284-1
doi: 10.1016/j.arr.2021.101537
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101537

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Ph Kemoun (P)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France; Dental Faculty, Toulouse Institute of Oral Medicine and Science. University of Toulouse, CHU of Toulouse. Toulouse, France.

I Ader (I)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

V Planat-Benard (V)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

C Dray (C)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

N Fazilleau (N)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), CNRS U5051, INSERM U1291, University of Toulouse, Toulouse, France.

P Monsarrat (P)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France; Dental Faculty, Toulouse Institute of Oral Medicine and Science. University of Toulouse, CHU of Toulouse. Toulouse, France; Artificial and Natural Intelligence Toulouse Institute ANITI, France.

B Cousin (B)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

J Paupert (J)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

M Ousset (M)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

A Lorsignol (A)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

I Raymond-Letron (I)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

B Vellas (B)

Department of Epidemiology and Public Health, CHU Toulouse, Toulouse, France; Gérontopôle, Department of Geriatrics, CHU Toulouse, Toulouse, France; Centre d'Epidémiologie et de Recherche en santé des POPulations. UMR 1295. University of Toulouse. Toulouse.

P Valet (P)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

T Kirkwood (T)

Ageing Research Laboratories, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.

J Beard (J)

ARC Centre of Excellence in Population Ageing Research (CEPAR), University of New South Wales, Sydney, Australia.

L Pénicaud (L)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France.

L Casteilla (L)

RESTORE Research Center, University of Toulouse, INSERM 1301, CNRS 5070, EFS, ENVT, Toulouse, France. Electronic address: louis.casteilla@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH